Dendritic Cells Loaded With MART-1 Peptide or Infected With Adenoviral Construct Are Functionally Equivalent in the Induction of Tumor-Specific Cytotoxic T Lymphocyte Responses in Patients With Melanoma

Journal of Immunotherapy

Volumn 23, Issue 1, 2000, Pages 168-176

  Philip, Ramila ^a   Alters, Susan E ^a   Brunette, Elisa ^a   Ashton, Jean ^a   Gadea, Jose ^a   Yau, Josephine ^a   Lebkowski, Jane ^a   Philip, Mohan ^a  

^a RPR Gencell   (United States)

Author keywords

Adenovirus; Cytotoxic T lymphocytes; Dendritic cells; Gene expression; Tumor associated antigen

Indexed keywords

CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN; INTERLEUKIN 4; MELANOMA ANTIGEN; TUMOR ANTIGEN;

ADENOVIRUS; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ADENOVIRUSES, HUMAN; ANTIGENS, NEOPLASM; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MELANOMA; NEOPLASM PROTEINS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0033950494     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-200001000-00020     Document Type: Article

References (35)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-96.
2. Flamand V, Sornasse K, Tielemans O, et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 1994; 24:605-10.
3. Paglia P, Chiodoni C, Rodolfo M. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996; 183:317-22.
4. Porgador A, Shyder D, Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 1996; 156:2918-26.
5. Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995; 182:255-60.
6. Ossevoort MA, Feltkamp MCW, Van Veen KJH, et al. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope based peptide vaccine in protection against a human papillomavirus type 16-induced tumor. J Immunother 1995; 18:86-94.
7. Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat Med 1995; 1:1297-1302.
8. Celluzi CM, Mayordomo JI, Storkus WJ, et al. Peptide pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 1996; 183:283-7.
9. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nat Med 1996; 2:52-8.
10. Inaba K, Young JW, Steinman RM. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J Exp Med 1987; 166:182-94.
11. Romani N, Koide S, Crowley M, et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989; 169:1169-78.
12. Young JW, Steinman RM. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J Exp Med 1990; 171:1315-32.
13. Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol 1993; 150:821-34.
14. Grabbe S, Beissert S, Schwarz T, et al. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today 1995; 16:117-21.
15. Townsend AR, McMichael AJ, Carter NP, et al. Cytotoxic T cell recognition of the nfluenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 1984; 39:13-25.
16. Townsend AR, Gotch FM, Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 1985; 42:457-67.
17. Kawakami Y, Eliyahu S, Delgado C, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994; 91:3515-19.
18. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanoma. J Exp Med 1994; 180:35-42.
19. Brichard V, Van Pel A, Wolfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178:489-95.
20. Arthur JF, Butterfield LH, Roth MD, et al. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 1997; 4:17-25.
21. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180:83-93.
22. Crouzet J, Naudin L, Orsini C, et al. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci 1997; 94:1414-19.
23. Philip R, Brunette E, Ashton J, et al. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors. Cancer Gene Ther 1998; 5:236-46.
24. Alijagic S, Moller P, Artuc M, et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 1995; 25:3100-7.
25. Henderson R, Nimgaonkar M, Watkins S, et al. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res 1996; 56:3763-70.
26. Reeves M, Royal R, Lam J, et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996; 56:5672-7.
27. Bhardwaj N, Bender A, Gonzalez N, et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest 1994; 94:797.
28. Song W, Kong HL, Carpenter H, et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997; 186:1247-56.
29. Wan Y, Bramson J, Carter R, et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum Gene Ther 1997; 8:1355-63.
30. Brossart P, Goldrath AW, Butz EA, et al. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol 1997; 158:3270-6.
31. Ribas A, Butterfield LH, McBride WH, et al. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res 1997; 57:2865-9.
32. Spahn G, Ziegner M, Dorken B, et al. Liposomal MUC-1-cDNA transfer into dendritic cells for the use as tumor vaccine. 4th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology, Supplement 104. Milan, Italy: Ricerca Scientifica Ed Educazione Permanente, University of Milan; 1996: 356.
33. Marincola FM, Rivoltini L, Salgaller ML, et al. Differential anti-MART-1/Melan A CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthydonors: evidence of in vivo priming by tumor cells. J Immunother 1996; 19:266-77.
34. Bakker A, Marland G, de Boer AJ, et al. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 1995; 55:5330-4.
35. Nanda NK, Sercarz EE. Induction of anti-self immunity to cure cancer. Cell 1995; 82:13.